Published in Science on January 27, 2012
Engineering H5N1 avian influenza viruses to study human adaptation. Nature (2012) 1.74
Naturally occurring swine influenza A virus PB1-F2 phenotypes that contribute to superinfection with Gram-positive respiratory pathogens. J Virol (2012) 1.57
The pH of activation of the hemagglutinin protein regulates H5N1 influenza virus replication and pathogenesis in mice. J Virol (2013) 1.57
Research funding. A framework for decisions about research with HPAI H5N1 viruses. Science (2013) 1.52
The future of research and publication on altered H5N1 viruses. J Infect Dis (2012) 1.39
MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies. Nat Biotechnol (2013) 1.21
Increased acid stability of the hemagglutinin protein enhances H5N1 influenza virus growth in the upper respiratory tract but is insufficient for transmission in ferrets. J Virol (2013) 1.13
Transmission studies resume for avian flu. Science (2013) 1.07
The pause on Avian H5N1 influenza virus transmission research should be ended. MBio (2012) 1.04
Identification and structural characterization of a broadly neutralizing antibody targeting a novel conserved epitope on the influenza virus H5N1 hemagglutinin. J Virol (2012) 1.00
The H5N1 moratorium controversy and debate. MBio (2012) 1.00
Ferretting out the facts behind the H5N1 controversy. Bioeng Bugs (2012) 0.84
Research on highly pathogenic H5N1 influenza virus: the way forward. MBio (2012) 0.84
A new synthesis for dual use research of concern. PLoS Med (2015) 0.83
The controversy over H5N1 transmissibility research: an opportunity to define a practical response to a global threat. Hum Vaccin Immunother (2013) 0.82
Potential strategies and biosafety protocols used for dual-use research on highly pathogenic influenza viruses. Rev Med Virol (2012) 0.82
Mono- and quadri-subtype virus-like particles (VLPs) containing H10 subtype elicit protective immunity to H10 influenza in a ferret challenge model. Vaccine (2016) 0.81
Principals, Agents, and the Intersection between Scientists and Policy-Makers: Reflections on the H5N1 Controversy. Front Public Health (2014) 0.80
Dual-use research debates and public health: better integration would do no harm. Front Public Health (2014) 0.80
Animal models for influenza virus transmission studies: a historical perspective. Curr Opin Virol (2015) 0.79
Engaging the normative question in the H5N1 avian influenza mutation experiments. Philos Ethics Humanit Med (2013) 0.76
Disparate foundations of scientists' policy positions on contentious biomedical research. Proc Natl Acad Sci U S A (2017) 0.75
Biosecurity and biosafety in research on emerging pathogens. Emerg Microbes Infect (2012) 0.75
One study, two paths: the challenge of dual-use research. Environ Health Perspect (2012) 0.75
The responsibility of the scientist. What can history teach us about how scientists should handle research that has the potential to create harm? EMBO Rep (2013) 0.75
Finding the missing heritability of complex diseases. Nature (2009) 67.95
Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med (2003) 27.97
Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science (2009) 25.61
Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med (2012) 22.75
Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science (2003) 18.34
Influenza-associated hospitalizations in the United States. JAMA (2004) 18.23
Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature (2009) 17.96
Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science (2005) 17.19
The Genome sequence of the SARS-associated coronavirus. Science (2003) 16.68
Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med (2005) 15.53
Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med (2009) 15.02
Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med (2005) 14.59
In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature (2009) 14.59
Mapping the antigenic and genetic evolution of influenza virus. Science (2004) 14.28
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med (2006) 14.21
Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature (2012) 14.17
Global patterns of influenza a virus in wild birds. Science (2006) 13.80
Airborne transmission of influenza A/H5N1 virus between ferrets. Science (2012) 13.48
Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A (2004) 12.39
Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol (2009) 12.13
Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution. Nature (2005) 11.99
Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature (2009) 11.34
Avian flu: influenza virus receptors in the human airway. Nature (2006) 11.28
Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis (2008) 11.01
Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol (2005) 10.77
Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet (2010) 10.75
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep (2010) 10.59
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature (2007) 10.40
Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med (2008) 10.27
The genomic and epidemiological dynamics of human influenza A virus. Nature (2008) 10.26
The allelic architecture of human disease genes: common disease-common variant...or not? Hum Mol Genet (2002) 10.08
The global circulation of seasonal influenza A (H3N2) viruses. Science (2008) 10.05
Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science (2006) 10.04
Large-scale sequence analysis of avian influenza isolates. Science (2006) 9.87
Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat Med (2002) 9.47
Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol (2005) 9.13
Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol (2003) 9.09
Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet (2004) 8.62
Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science (2009) 8.61
Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog (2007) 8.61
Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio (2012) 8.54
A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science (2007) 8.38
Activation of influenza A viruses by trypsin treatment. Virology (1975) 8.07
Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA (2006) 8.06
Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J Virol (2005) 7.88
Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science (2009) 7.80
Novel orthobunyavirus in Cattle, Europe, 2011. Emerg Infect Dis (2012) 7.62
Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature (2006) 7.56
Aetiology: Koch's postulates fulfilled for SARS virus. Nature (2003) 7.51
The severe acute respiratory syndrome. N Engl J Med (2003) 7.48
Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model. J Virol (2005) 7.36
Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med (2011) 7.29
Are we ready for pandemic influenza? Science (2003) 7.20
Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol (2007) 7.18
Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One (2008) 6.98
Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med (2005) 6.83
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med (2005) 6.77
Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science (2004) 6.70
Avian flu: isolation of drug-resistant H5N1 virus. Nature (2005) 6.66
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet (2003) 6.52
Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature (2006) 6.46
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature (2013) 6.39